betaine has been researched along with Angelman Syndrome in 3 studies
glycine betaine : The amino acid betaine derived from glycine.
Angelman Syndrome: A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence happy); jerky puppetlike movements (hence puppet); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, J | 1 |
Bichell, TJ | 2 |
Golden, S | 1 |
Anselm, I | 2 |
Waisbren, S | 2 |
Bacino, CA | 2 |
Peters, SU | 2 |
Bird, LM | 2 |
Kimonis, V | 2 |
Dos Santos, JF | 1 |
Mota, LR | 1 |
Rocha, PH | 1 |
Ferreira de Lima, RL | 1 |
Glaze, DG | 1 |
Shinawi, LM | 1 |
Barbieri-Welge, R | 1 |
Nespeca, M | 1 |
Sanborn, E | 1 |
Sun, Q | 1 |
O'Brien, WE | 1 |
Beaudet, AL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome[NCT00348933] | 90 participants (Actual) | Interventional | 2006-07-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT00348933)
Timeframe: Baseline, 1 year
Intervention | ng/mL (Mean) |
---|---|
Treatment (Metafolin/Creatine/Betaine/B12) | 77 |
"Primary:~Bayley Scales of Infant Development measures Mental Developmental Index standard scores 0 (least skilled) - 100 (most skilled) Psychomotor Developmental Index standard scores 0 (least skilled - 10 (most skilled) Vineland Adaptive Behavior Scales (VABS), Communication standard scores 0 (least skilled) - 100 (most skilled) Daily Living Skills standard scores 0 (least skilled) - 100 (most skilled) Socialization standard scores 0 (least skilled) - 100 (most skilled) Motor Skills standard scores 0 (least skilled) - 100 (most skilled) Preschool Language Scale (PLS), Auditory Comprehension 0 (least skilled) - 100 (most skilled) Expressive Communication 0 (least skilled) - 100 (most skilled)" (NCT00348933)
Timeframe: Baseline, 1 year
Intervention | units on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Bayley Scales Mental Developmental Index | Bayley Scales Psychomotor Developmental Index | VABS Communication | VABS Daily Living Skills | VABS Socialization | VABS Motor Skills | PLS Auditory Comprehension | PLS Expressive Communication | |
Treatment (Metafolin/Creatine/Betaine/B12) | 5.7 | 4.7 | 5.8 | 3.7 | 4.7 | 2.0 | 2.0 | 5.5 |
(NCT00348933)
Timeframe: Baseline, 1 year
Intervention | mmol/L (Mean) | |||||
---|---|---|---|---|---|---|
Betaine | Creatine | Dimethylglycine | Guanidinoacetate | Homocysteine | Methionine | |
Treatment (Metafolin/Creatine/Betain/B12) | 206.9 | 83.3 | 93.7 | 0.11 | 2.3 | 5.5 |
2 trials available for betaine and Angelman Syndrome
Article | Year |
---|---|
A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndrome.
Topics: Angelman Syndrome; Betaine; Child; Double-Blind Method; Folic Acid; Gastrointestinal Agents; Humans; | 2019 |
Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.
Topics: Adolescent; Angelman Syndrome; Betaine; Child; Child, Preschool; Chromosomes, Human, Pair 15; DNA Me | 2010 |
1 other study available for betaine and Angelman Syndrome
Article | Year |
---|---|
A modified MS-PCR approach to diagnose patients with Prader-Willi and Angelman syndrome.
Topics: Angelman Syndrome; Betaine; Chromosomes, Human, Pair 15; DNA Methylation; Genomic Imprinting; Humans | 2016 |